Chijioke Okereke, MD

Chijioke Okereke, MD

Hometown: Boston, Massachusetts
Medical School: American University of Antigua College of Medicine
Residency: Medical College of Georgia
Research/Academic Interests: Translational research and clinical trials in Acute Myelocytic Leukemia and Multiple Myeloma; Cellular and Immuno-therapy; Gastrointestinal cancers
Bio: Anything that involves food, traveling and time spent with family. I also love movies (#1 Sci-Fi), running, hiking, museums, reading, music, documentaries, video games and watching sports. When traveling, I explore, learn and familiarize myself with a countries’ and/or area’s culture.

Selected Publications/Abstracts

  • Okereke, C., Fox, A.D., Le, T., Abbagoni, S., Jillella, A.P., Bryan, L.J., Anwar, T., Mian, M.A. & Kota, V.. (2021, Nov). The Increased Use of Diagnostic Studies over Time in Acute Myelogenous Leukemia Patients. Blood, 138(Supplement 1), 4979.
  • Fox, A.D., Okereke, C., Le, T., Jillella, A.P., Bryan, L.J., Anwar, T., Mian, M.A., Bradshaw, D., Kolhe, R., Savage, N.M., Ajebo, G., Padala, S., Abbagoni, S., & Kota, V.. (2021, Nov). Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML). Blood, 138(Supplement 1), 1226.
  • Branham, Z. C., Okereke, C., Shoukier, M., Bradshaw, D., Kolhe, R., Jillella, A. P., & Kota, V. K. (2022). Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy. In Blood (Vol. 140, Issue Supplement 1, pp. 8929–8929). American Society of Hematology. doi:10.1182/blood-2022-164963